CSRC approved Tianhai Electronics' IPO registration on the Shenzhen Stock Exchange.
On March 12, the China Securities Regulatory Commission issued the "Reply on Approving the Initial Public Offering of Shares of Tianhai Auto Electronics Group Co., Ltd."
On March 12th, the China Securities Regulatory Commission issued the "Approval for the First Public Offering of Shares by Tianhai Automobile Electronic Group Co., Ltd." It is reported that Tianhai Electronics plans to be listed on the main board of the Shenzhen Stock Exchange, with CMSC as its sponsoring institution, planning to raise 2.46042 billion yuan.
According to the prospectus, Tianhai Electronics is committed to providing solutions such as automotive transmission systems, connectivity systems, and intelligent controls for automotive manufacturers. The company's main business includes research and development, production, and sales of automotive harnesses, automotive connectors, automotive electronics, and other automotive components, mainly used in the manufacturing of new energy vehicles and traditional fuel vehicles.
To date, the company has become a leading domestic brand in automotive harnesses and automotive connectors. Compared with A-share listed companies that primarily engage in independent automotive harness business, the company ranks first in automotive harness business revenue; compared with A-share listed companies that primarily engage in automotive connector business, the company ranks in the top three in automotive connector business revenue.
Related Articles

Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!
Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


